Four academics from the University of Oxford have been elected to the National Academy of Sciences in the US this year as international members, including former Institute Director Andrew McMichael.
Professor Adam Mead is Editor-in-Chief and Graham Collins and Deborah Hay two of the editors for the eighth edition of this key reference work, now in its sixth decade.
A new study led by the Fairfax Group at the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.
Facility Manager Michalina Mazurczyk, based in the MRC Weatherall Institute of Molecular Medicine, has been appointed as Technician Champion for the second year.
Professor Oliver Bannard has been awarded funding for an 8-year research programme investigating how our immune systems establish antibody-mediated immunity following vaccination and during infection.
An international collaboration, initiated by the Jackson Group at the MRC WIMM, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.
A collaboration between the Drakesmith and Higgs Groups at the MRC WIMM has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.
Associate Professor Adam Wilkinson has received the 2025 Janet Rowley Award from the International Society for Experimental Haematology for his outstanding contributions in the field of hematopoietic stem cell biology.
For International Women's Day on 8th March 2025, women from the MRC WIMM reflect on why this day is so important, the barriers and biases women can face in their careers, and which women have inspired them.
For Rare Disease Day on the 28th February, we spoke to three of our researchers about their work, discussing both the challenges and importance of researching and treating rare diseases.
The Therapy Acceleration Lab (TAL) at the MRC WIMM was recently accredited by the United Kingdom Accreditation Service (UKAS) to the ISO 17025:2017 Standard as a testing laboratory, No. 28562.
Global biopharma company GSK invests up to \u00a350 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
![\"Oxford](\"https://www.imm.ox.ac.uk/news/professor-andrew-mcmichael-elected-to-the-us-national-academy-of-sciences/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n